Fred Ausubel Email

Interim CSO . Octagon Therapeutics

,

Location

LinkedIn

Current Roles

Employees:
13
Revenue:
$1.9M
About
Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.
Octagon Therapeutics Address
127 Western Ave
null, null
United States
Octagon Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.